Oh C, Chung H, Kim Y, Kim J
Nutrients. 2025; 17(5).
PMID: 40077633
PMC: 11901931.
DOI: 10.3390/nu17050763.
Zhou J, Lamichhane N, Xu Z, Wang J, Quynh V, Huang J
PLoS One. 2025; 20(2):e0314678.
PMID: 39946356
PMC: 11824959.
DOI: 10.1371/journal.pone.0314678.
Hacker K, Bedell A
Transl Gastroenterol Hepatol. 2025; 10:15.
PMID: 39944576
PMC: 11811567.
DOI: 10.21037/tgh-24-38.
Xiao Y, Meng X, Luo Q, Hou X, Jin J, Zhong X
Therap Adv Gastroenterol. 2025; 18:17562848251314819.
PMID: 39917729
PMC: 11800259.
DOI: 10.1177/17562848251314819.
Berentsen B, Thuen C, Hillestad E, Steinsvik E, Hausken T, Hatlebakk J
JMIR Hum Factors. 2025; 12:e43618.
PMID: 39899743
PMC: 11809937.
DOI: 10.2196/43618.
The impact of locus of control on somatic and psychological profiles of patients with irritable bowel syndrome engaging in aerobic exercise.
Prospero L, Riezzo G, DAttoma B, Ignazzi A, Bianco A, Franco I
Sci Rep. 2025; 15(1):3966.
PMID: 39893252
PMC: 11787329.
DOI: 10.1038/s41598-025-88466-7.
Study of dynamic brain function in irritable bowel syndrome via Hidden Markov Modeling.
Jing C, Liu T, Li Q, Zhang C, Sun B, Yang X
Front Neurosci. 2025; 18:1515540.
PMID: 39872994
PMC: 11769953.
DOI: 10.3389/fnins.2024.1515540.
Chinese herbal formula Tongxie Yaofang granules for diarrhoea-predominant irritable bowel syndrome: a randomised, double-blind, placebo-controlled, phase II trial.
Liang S, Cheng H, Zhang Q, Han M, Li Y, Cao H
BMJ Open. 2025; 15(1):e088410.
PMID: 39870499
PMC: 11772933.
DOI: 10.1136/bmjopen-2024-088410.
Colonoscopic administration of probiotics to treat irritable bowel syndrome with predominant diarrhea: a randomized placebo-controlled clinical trial.
Wei J, Zhang P, Yang Z, Liu L, Lian T, Isomoto H
Surg Endosc. 2025; 39(3):1893-1901.
PMID: 39849073
DOI: 10.1007/s00464-025-11542-6.
Efficacy and Safety of a Mixture of Microencapsulated Sodium Butyrate, Probiotics, and Short Chain Fructooligosaccharides in Patients with Irritable Bowel Syndrome-A Randomized, Double-Blind, Placebo-Controlled Study.
Gasiorowska A, Romanowski M, Walecka-Kapica E, Kaczka A, Chojnacki C, Padysz M
J Clin Med. 2025; 14(1.
PMID: 39797089
PMC: 11720862.
DOI: 10.3390/jcm14010006.
Efficacy of Amitriptyline in Irritable Bowel Syndrome: A Systematic Review and Meta-analysis.
Iqbal M, Hira S, Saeed H, Shahid S, Butt S, Rashid K
J Neurogastroenterol Motil. 2025; 31(1):28-37.
PMID: 39779201
PMC: 11735204.
DOI: 10.5056/jnm24084.
Assessing the Impact of Irritable Bowel Syndrome on Quality of Life in Patients at Family Medicine and Primary Health Care Clinics of the National Guard Health Affairs, Riyadh.
AlDosari M, Alotaibi R, Algahtani M, Alshammari T, Almziri B
Cureus. 2024; 16(12):e76158.
PMID: 39717523
PMC: 11665739.
DOI: 10.7759/cureus.76158.
Spasmolytic Activity and Anti-Inflammatory Effect of Novel Mebeverine Derivatives.
Stoyanova M, Milusheva M, Gledacheva V, Stefanova I, Todorova M, Kircheva N
Biomedicines. 2024; 12(10).
PMID: 39457637
PMC: 11505310.
DOI: 10.3390/biomedicines12102321.
Digital Health Interventions Are Effective for Irritable Bowel Syndrome Self-Management: A Systematic Review.
DSilva A, Hua N, Modayil M, Seidel J, Marshall D
Dig Dis Sci. 2024; 70(2):644-664.
PMID: 39402208
PMC: 11839690.
DOI: 10.1007/s10620-024-08672-7.
Neuroplasticity of the white matter tracts underlying recovery of diarrhea-predominant irritable bowel syndrome following acupuncture treatment.
Li J, Ng W, Liu Y, Fang X, Wang Z, Pei L
Front Neurosci. 2024; 18:1383041.
PMID: 39364438
PMC: 11447489.
DOI: 10.3389/fnins.2024.1383041.
Is orthorexia nervosa a hidden threat impacting quality of life in IBS patients?.
Kip M, Kaya N, Capar A
Ir J Med Sci. 2024; 193(6):2761-2771.
PMID: 39289312
DOI: 10.1007/s11845-024-03805-3.
A Case Study in the IBS-C Management Continuum: Assessing Patient Response and Tailoring Treatment.
Ahuja N
Gastroenterol Hepatol (N Y). 2024; 20(7):383-427.
PMID: 39206030
PMC: 11348549.
Evidence-Based Clinical Guidelines for Chronic Constipation 2023.
Ihara E, Manabe N, Ohkubo H, Ogasawara N, Ogino H, Kakimoto K
Digestion. 2024; 106(1):62-89.
PMID: 39159626
PMC: 11825134.
DOI: 10.1159/000540912.
DOMINO trial analysis: evaluation of the diet effects on symptoms in IBS subtypes.
Di Rosa C, Van den Houte K, Altomare A, Guarino M, Besard L, Arts J
Therap Adv Gastroenterol. 2024; 17:17562848241255296.
PMID: 39086991
PMC: 11289810.
DOI: 10.1177/17562848241255296.
Is the Mediterranean Low Fodmap Diet Effective in Managing Irritable Bowel Syndrome Symptoms and Gut Microbiota? An Innovative Research Protocol.
Kasti A, Katsas K, Petsis K, Lambrinou S, Synodinou K, Kapetani A
Nutrients. 2024; 16(11).
PMID: 38892525
PMC: 11174440.
DOI: 10.3390/nu16111592.